TB Near Point-of-Care Toolkit Boosts TB Testing Worldwide
The World Health Organization (WHO) and the Stop TB Partnership Global Laboratory Initiative (GLI) have published a TB near point-of-care and swab-based testing toolkit to accelerate diagnosis. This toolkit provides practical guidance to bring faster, accurate TB testing closer to patients, reducing delays in treatment. It targets frontline clinics, community health posts, and busy hospitals, offering clear steps that can be adopted even in resource-limited settings. The goal is to shorten the time from symptom onset to diagnosis, improving outcomes for many patients.
What the toolkit covers
The TB near point-of-care toolkit includes a comprehensive set of materials to support the implementation of near point-of-care nucleic acid amplification tests (NPOC-NAATs) using sputum and tongue swabs. It supports diagnosing TB with and without drug resistance, enabling faster treatment decisions in clinics and outreach sites. The toolkit also provides guidance on training, quality control, procurement, data reporting, and program integration to streamline adoption across health systems.
Tongue swabs offer a practical, non-invasive alternative when sputum collection is difficult, expanding access in community settings and remote areas. This approach complements existing testing methods and helps reach key populations who may face barriers to traditional sample collection.
How it helps health systems
By guiding teams through procurement, training, quality assurance, and data reporting, the toolkit helps health ministries deploy rapid TB testing where traditional labs are scarce. It emphasizes user-friendly workflows, rapid result reporting, and integration with patient care pathways. The near point-of-care focus can reduce patient delays and support timely initiation of therapy, which is crucial for disease control.
Laboratories and clinics can select appropriate NAAT platforms, strengthen quality assurance, and align reporting with national TB programs. The toolkit fosters capacity-building so health workers at all levels can confidently use new testing technologies while maintaining accuracy and safety standards.
Access and updates
Full toolkit materials, guidelines, and training resources are available through the WHO and GLI collaboration. The release notes ongoing TB updates via the TB CAB Weekly Newsletter (Issue #14, 3 May 2026), ensuring referenced guidance stays current for practitioners.
For policymakers and clinicians, this means faster access to validated near point-of-care testing methods and better detection of drug-resistant TB. The TB near point-of-care approach aligns with global efforts to curb TB more quickly and effectively.
Conclusion: TB near point-of-care testing becomes a practical reality for faster, better care.
